Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $27.00 at Bank of America

Key Points

• Bank of America has raised its price target for Phibro Animal Health (NASDAQ:PAHC) from $19.00 to $27.00, while maintaining an "underperform" rating on the stock.
• Other analysts have varying ratings on the stock, with Morgan Stanley setting a target price of $34.00 and BNP Paribas upgrading to a "neutral" rating with a target of $24.00.
• The stock has experienced volatility, trading down to $36.76 recently, with an average analyst price target of $28.40 reflecting a generally cautious outlook.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) had its price objective upped by research analysts at Bank of America from $19.00 to $27.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has an "underperform" rating on the stock. Bank of America's price objective indicates a potential downside of 26.41% from the company's current price.

Several other analysts also recently issued reports on the company. BNP Paribas upgraded Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Morgan Stanley set a $34.00 target price on Phibro Animal Health in a research report on Thursday, August 28th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a research note on Monday, June 16th. Finally, JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $25.00 to $35.00 in a report on Monday, July 7th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Reduce" and an average target price of $28.40.

Phibro Animal Health Stock Down 1.0%

NASDAQ PAHC traded down $0.38 during trading hours on Friday, reaching $36.69. 728,704 shares of the company traded hands, compared to its average volume of 270,440. The company has a 50 day moving average of $29.59 and a two-hundred day moving average of $24.53. Phibro Animal Health has a 12 month low of $16.16 and a 12 month high of $38.83. The stock has a market capitalization of $1.49 billion, a PE ratio of 31.09, a PEG ratio of 0.54 and a beta of 0.88. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.05. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The firm had revenue of $378.70 million for the quarter, compared to analysts' expectations of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, equities analysts expect that Phibro Animal Health will post 1.95 earnings per share for the current year.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently bought and sold shares of the stock. Nuveen LLC bought a new position in shares of Phibro Animal Health during the 1st quarter worth about $10,312,000. Invesco Ltd. increased its stake in Phibro Animal Health by 92.3% during the first quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after acquiring an additional 186,087 shares during the period. Ranger Investment Management L.P. raised its holdings in Phibro Animal Health by 101.1% in the 2nd quarter. Ranger Investment Management L.P. now owns 357,970 shares of the company's stock valued at $9,143,000 after acquiring an additional 179,975 shares in the last quarter. Axecap Investments LLC bought a new stake in shares of Phibro Animal Health in the 1st quarter worth approximately $3,696,000. Finally, Millennium Management LLC grew its holdings in shares of Phibro Animal Health by 74.3% during the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company's stock worth $7,733,000 after purchasing an additional 154,281 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.